indazoles has been researched along with Proteinuria in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 16 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anttila, M; Åvall Lundqvist, E; Birrer, MJ; Bjørge, L; dePont Christensen, R; Dimoula, M; Hietanen, S; Krog Vistisen, A; Lindahl, G; Lund, B; Mäenpää, JU; Malander, S; Mirza, MR; Nyvang, GB; Peen, U; Roed, H; Staff, S; Werner, TL; Ør Knudsen, A | 1 |
| Andreeva, S; Basgen, JM; Castonguay, P; Clark, AR; Dubois, F; Dvela-Levitt, M; Garrett, MR; Greka, A; Hoffmann, SC; Hopkins, CR; Johnson, AC; Jung, JY; Kim, S; Lander, ES; Montesinos, MS; Reichardt, J; Sidhom, EH; Sieber, J; Weins, A; Wieder, N; Zhou, Y | 1 |
| Hasebe, N; Kabara, M; Maruyama, K; Matsuki, M; Nakagawa, N; Ogawa, Y; Shindo, M; Suzuki, A | 1 |
| Bindels, RJM; van der Wijst, J | 1 |
| Gunderson, CC; Matulonis, U; Moore, KN | 1 |
| Akaza, H; Chen, C; Kanayama, H; Kim, S; Naito, S; Ozono, S; Shinohara, N; Tarazi, J; Tomita, Y; Tsukamoto, T; Ueda, T; Uemura, H | 1 |
| Bagcivan, I; Karadas, B; Parlak, M; Temiz, TK; Turgut, B; Turgut, NH | 1 |
| Fujisawa, M; Harada, K; Imai, S; Miyake, H; Miyazaki, A | 1 |
| Atkinson, BJ; Cauley, DH; Chen, AH; Land, JD; Tannir, NM | 1 |
| Buelli, S; Corna, D; Guglielmotti, A; Locatelli, M; Morigi, M; Perico, N; Pezzotta, A; Remuzzi, A; Remuzzi, G; Rottoli, D; Zanchi, C; Zoja, C | 1 |
| Fujisawa, M; Imai, S; Miyake, H | 1 |
| Adomi, S; Minami, T; Nose, K; Nozawa, M; Ohzeki, T; Saito, Y; Shimizu, N; Sugimoto, K; Uemura, H; Yoshimura, K | 1 |
| Kichenadasse, G; Mangoni, AA; Rowland, A; Sorich, MJ; Woodman, RJ | 1 |
| Biondi, G; Ble, A; Bombardieri, S; Di Loreto, G; Guglielmotti, A; Mosca, M; Remuzzi, G; Ruggenenti, P | 1 |
| Akaza, H; Fujimoto, H; Imai, K; Kanayama, HO; Naito, S; Nakazawa, H; Ozono, S; Shinohara, N; Tomita, Y; Uemura, H; Umeyama, Y | 1 |
| Andrews, L; Fishman, M; Gorbunova, V; Jonasch, E; Larkin, J; Negrier, S; Olivier, K; Pyle, L; Staehler, M; Wood, L | 1 |
| Armand, JP; Mir, O; Ropert, S | 1 |
| Benedetti, G; Bertani, T; Corna, D; Donadelli, R; Guglielmotti, A; Morigi, M; Pinza, M; Remuzzi, G; Zoja, C | 1 |
2 review(s) available for indazoles and Proteinuria
| Article | Year |
|---|---|
Management of the toxicities of common targeted therapeutics for gynecologic cancers.
Topics: Anemia; Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Autoimmune Diseases; Bevacizumab; Diarrhea; Epistaxis; Fatigue; Female; Genital Neoplasms, Female; Headache; Hemorrhage; Humans; Hypertension; Indazoles; Intestinal Perforation; Molecular Targeted Therapy; Nausea; Neutropenia; Poly(ADP-ribose) Polymerase Inhibitors; Precision Medicine; Proteinuria; Pyrimidines; Risk Assessment; Sulfonamides; Vomiting; Water-Electrolyte Imbalance | 2018 |
[Oral drugs inhibiting the VEGF pathway].
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Asthenia; Axitinib; Benzenesulfonates; Humans; Hypertension; Imidazoles; Indazoles; Indoles; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Phthalazines; Piperidines; Proteinuria; Pyridines; Pyrroles; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib; Vascular Endothelial Growth Factor A | 2007 |
7 trial(s) available for indazoles and Proteinuria
| Article | Year |
|---|---|
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Topics: Aged; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Endometrioid; Disease Progression; Female; Humans; Hypertension; Indazoles; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Progression-Free Survival; Proteinuria; Thrombocytopenia | 2019 |
Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Axitinib; Carcinoma, Renal Cell; Diarrhea; Disease-Free Survival; Female; Hand-Foot Syndrome; Humans; Hypertension; Hypothyroidism; Imidazoles; Indazoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Proteinuria; Sorafenib; Treatment Outcome; Young Adult | 2013 |
Proteinuria with first-line therapy of metastatic renal cell cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bevacizumab; Carcinoma, Renal Cell; Cohort Studies; Everolimus; Female; Humans; Indazoles; Kidney Neoplasms; Male; Middle Aged; Prospective Studies; Proteinuria; Pyrimidines; Retrospective Studies; Sulfonamides | 2016 |
Acceleration of Proteinuria without Significant Impact on Renal Function and Its Protection by Angiotensin II Receptor Blocker in Rats Treated with Axitinib.
Topics: Angiotensin Receptor Antagonists; Animals; Axitinib; Humans; Imidazoles; Indazoles; Kidney; Protein Kinase Inhibitors; Proteinuria; Rats; Rats, Sprague-Dawley | 2016 |
Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data.
Topics: Carcinoma, Renal Cell; Female; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Proportional Hazards Models; Proteinuria; Pyrimidines; Pyrroles; Risk Factors; Sulfonamides; Sunitinib; Survival Analysis; Vascular Endothelial Growth Factor A | 2016 |
Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritis.
Topics: Acute Disease; Adult; Chemokine CCL2; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Indazoles; Kidney Diseases; Lupus Nephritis; Male; Middle Aged; Placebos; Propionates; Prospective Studies; Proteinuria; Remission Induction | 2011 |
Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: a phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Axitinib; Biomarkers, Tumor; Carcinoma, Renal Cell; Disease-Free Survival; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Male; Middle Aged; Prognosis; Proteinuria; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
9 other study(ies) available for indazoles and Proteinuria
| Article | Year |
|---|---|
A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
Topics: Animals; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Indazoles; Mutation; Podocytes; Proteinuria; rac1 GTP-Binding Protein; Rats; Rats, Inbred Dahl; Rats, Transgenic; Small Molecule Libraries; TRPC Cation Channels | 2017 |
Pazopanib-induced Endothelial Injury with Podocyte Changes.
Topics: Adult; Humans; Indazoles; Male; Nephrotic Syndrome; Podocytes; Proteinuria; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma; Sulfonamides | 2018 |
Renal physiology: TRPC5 inhibition to treat progressive kidney disease.
Topics: Animals; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Indazoles; Mutation; Podocytes; Proteinuria; rac1 GTP-Binding Protein; Rats; Rats, Inbred Dahl; Rats, Transgenic; Small Molecule Libraries; TRPC Cation Channels | 2018 |
Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Female; Fetal Growth Retardation; Guanylate Cyclase; Indazoles; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Pre-Eclampsia; Pregnancy; Proteinuria; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Second Messenger Systems; Suramin; Vasodilation; Vasodilator Agents | 2013 |
Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib.
Topics: Aged; Antineoplastic Agents; Asian People; Axitinib; Carcinoma, Renal Cell; Female; Glomerular Filtration Rate; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Proteinuria; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies | 2015 |
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.
Topics: Animals; Chemokine CCL2; Disease Models, Animal; In Vitro Techniques; Indazoles; Macrophages; Male; Monocytes; Podocytes; Polycystic Kidney, Autosomal Dominant; Propionates; Proteinuria; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; RNA, Messenger | 2015 |
Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Axitinib; Carcinoma, Renal Cell; Disease-Free Survival; Female; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Proteinuria; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomes.
Topics: Axitinib; Carcinoma, Renal Cell; Diarrhea; Dysphonia; Fatigue; Humans; Hypertension; Imidazoles; Indazoles; Kidney Neoplasms; Nausea; Protein Kinase Inhibitors; Proteinuria; Vomiting | 2014 |
Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease.
Topics: Animals; Antibodies, Antinuclear; Blood Urea Nitrogen; Chemokine CCL2; Female; Humans; Indazoles; Inflammation Mediators; Kidney; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB; Propionates; Proteinuria; Rats | 1998 |